Abstract:Purpose: To compare the hippocampus (HPC) dose reduced by HPC-sparing intensity modulated radiation therapy (IMRT) plans between nasopharyngeal carcinoma (NPC) patients of stages T1-T2 and T3-T4, and to investigate the correlation between the dose of the HPC and the volume of PTVnx70 (the planning target volume of the primary tumor in the nasopharynx that received 70 Gy). Methods and Materials: Fifty-eight NPC patients were retrospectively evaluated. HPC-nonsparing IMRT or sparing IMRT for each patient was designed according to the protocol for NPC. Dose-volume histogram was used to evaluate the IMRT plans for each patient. The difference in values of HPC parameters (eg, D-min[NS] - D-min[S]) between HPC-sparing and nonsparing plans in the stage T1-T2 group and stage T3-T4 group were compared. The correlations between the dose of the HPC and the volume of PTVnx70 were analyzed. Results: There was no significance between HPC-sparing and nonsparing IMRT plans. Compared with the HPC-nonsparing plans, the HPC-sparing plans significantly decreased both dosimetric and volumetric parameters for the HPC (P < .05), except for D-min, D-98%,D- and V-5. The medians of D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-30[NS] - V-30[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] in the T1-T2 group were significantly lower than in the T3-T4 group (P < .05), respectively. Both dosimetric and volumetric parameters for the HPC were positively correlated with the volume of PTVnx70 in HPC-sparing and HPC-nonsparing plans (P < .05). The volume of PTVnx70 was positively correlated with D-median[NS] - D-median[S], D-mean[NS] - D-mean[S], D-40%[NS] - D-40%[S], V-40[NS] - V-40[S] and V-50[NS] - V-50[S] (P < .05). Conclusions: HPC-sparing IMRT plans may play a more significant role in decreasing D-median, D-mean, D-40%,D- and V-30-V-50 of HPC in NPC patients with stages T3-T4 than those in stages T1-T2. PTVnx70 volume of NPC patients is positively correlated with all dosimetric and volumetric parameters of HPC and the reduction of specific dosage parameters by HPC-sparing IMRT plans. (c) 2024 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience

A detailed dosimetric comparative study of IMRT and VMAT in normal brain tissues for nasopharyngeal carcinoma patients treated with radiotherapy

Prospective Matched Study on Comparison of Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Dosimetry, Delivery Efficiency and Outcomes.

Volumetric modulated arc therapy for nasopharyngeal carcinoma: A dosimetric comparison with TomoTherapy and step-and-shoot IMRT

Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

[Dosimetric Verification and Clinical Efficacy of Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma].

Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.

Analysis of intensity-modulated radiotherapy for untreated patients with nasopharyngeal carcinoma

The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.

Which T Category Of Nasopharyngeal Carcinoma May Benefit Most From Volumetric Modulated Arc Therapy Compared With Step And Shoot Intensity Modulated Radiation Therapy

Comparison of Dosimetric Benefits of Three Precise Radiotherapy Techniques in Nasopharyngeal Carcinoma Patients Using a Priority-Classified Plan Optimization Model

Dosimetric Analysis of Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma

Volumetric Modulated Arc Therapy Versus Tomotherapy for Late T-stage Nasopharyngeal Carcinoma.

Comparison and evaluation of VMAT and IMRT for the treatment of initial treated nasopharyngeal carcinoma

Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison

The Relations of Dosimetric Parameters with Long-Term Outcomes and Late Toxicities in Advanced T-stage Nasopharyngeal Carcinoma with IMRT.

Analysis of Late Toxicity in Nasopharyngeal Carcinoma Patients Treated with Intensity Modulated Radiation Therapy.

Clinical study of docetaxel plus nedaplatin combined with concurrent intensity-modulated radiotherapy for locally-advanced nasopharyngeal carcinoma

High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity.

Effectiveness And Toxicities Of Intensity-Modulated Radiotherapy For Patients With Locally Recurrent Nasopharyngeal Carcinoma

Late Toxicities after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Patient and Treatment-Related Risk Factors